HeBe

The aim of HeBe is to identify blood factors that have a rejuvenating or aging effect on the human brain. The results will improve the diagnosis of Alzheimer's disease or other neurodegenerative diseases in their earliest stages. They will also be useful for detecting individuals more susceptible to developing these diseases, predicting their prognosis, monitoring their progression and the effectiveness of a possible treatment.

This project receives funding from the European Research Council (ERC) within the framework of the European Union's Horizon 2020 research and innovation program (grant agreement no. 948677).